Paradowski Marek, Szablewski Mariusz, Piatas Sławomir, Urbaniak Anna, Majda Jacek
Zaklad Diagnostyki Laboratoryjnej i Biochemii Klinicznej, Katedry Diagnostyki Laboratoryjnej, Uniwersytetu Medycznego w łodzi.
Przegl Epidemiol. 2006;60(3):617-25.
At present, the only reasonable action which reduces the case fatality rate at patients with severe sepsis and septic shock is the early diagnosis of infection which allows to introduce effective therapy. Although sepsis is a typical clinical syndrome recognized in connection with infection, it should be remembered that infection does not reveal itself in each case. Also bacteriological blood culture does not confirm it in most cases. In view of few characteristic, especially in the initial phase of sepsis, clinical symptoms, laboratory investigations describing the present state of immune response of organism find a huge application. In our work we made an attempt to bring closer the latest markers of inflammatory reaction and infection such as acute phase proteins procalcytonin (PCT), proANP and lipopolisacharyde binding protein (LBP).
目前,降低严重脓毒症和脓毒性休克患者病死率的唯一合理措施是早期诊断感染,以便能够开展有效治疗。尽管脓毒症是一种与感染相关的典型临床综合征,但应记住,并非每种情况下都会出现感染迹象。而且在大多数情况下,血培养也无法确诊。鉴于脓毒症的特征较少,尤其是在其初始阶段,描述机体免疫反应当前状态的临床症状和实验室检查具有重要应用价值。在我们的研究中,我们试图更深入地探讨炎症反应和感染的最新标志物,如急性期蛋白降钙素原(PCT)、前心钠素(proANP)和脂多糖结合蛋白(LBP)。